Active Ingredient (In Each Caplet)
Acetaminophen 650 mg
The following Structured Product Label (SPL) was submitted to the FDA by Wal-mart Stores Inc for the product Equate 8hr Arthritis Pain Relief (NDC 49035-741). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each caplet), purpose, uses, warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Acetaminophen 650 mg
Pain reliever/fever reducer
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include:
If a skin reaction occurs, stop use and seek medical help right away.
liver disease
taking the blood thinning drug warfarin
These could be signs of a serious condition.
ask a health professional before use.
Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
adults |
|
under 18 years of age |
|
carnauba wax, colloidal silicon dioxide, croscarmellose sodium, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, polyethylene glycol, polysorbate 80, povidone, pregelatinized starch, stearic acid, titanium dioxide
1-888-287-1915
Compare to Tylenol® 8HR Arthritis Pain Active Ingredient
8HR Arthritis Pain Relief
Acetaminophen
Extended-Release Tablets, 650mg
Pain Reliever/Fever Reducer
For the Temporary Relief of Minor Arthritis Pain
DO NOT USE WITH OTHER MEDICINES CONTAINING ACETAMINOPHEN
325 CAPLETS†
650 mg EACH
†Capsule-Shaped Tablets
Actual Size
* Please review the disclaimer below.